HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL Drug Patent Profile
✉ Email this page to a colleague
When do Hydrochlorothiazide And Olmesartan Medoxomil patents expire, and what generic alternatives are available?
Hydrochlorothiazide And Olmesartan Medoxomil is a drug marketed by Alkem Labs Ltd and is included in one NDA.
The generic ingredient in HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL is hydrochlorothiazide; olmesartan medoxomil. There are thirty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrochlorothiazide And Olmesartan Medoxomil
A generic version of HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL was approved as hydrochlorothiazide; olmesartan medoxomil by ALKEM LABS LTD on July 11th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL?
- What are the global sales for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL?
- What is Average Wholesale Price for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL?
Summary for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 26 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Altasciences Company Inc. | Phase 1 |
| Pharmtechnology LLC | Phase 1 |
| Altasciences Company, Inc. | Phase 1 |
See all HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL clinical trials
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 207037-001 | Jul 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 207037-002 | Jul 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 207037-003 | Jul 11, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
